MedTrace Logo

Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section

NCT01630187 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2013-05-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of two doses of carbetocin (50 mcg vs 100 mcg) in preventing uterine atony during elective cesarean section.

Conditions

  • Uterine Atony
  • Post-partum Hemorrhage

Interventions

DRUG

Carbetocin

Administration of carbetocin 50 mcg , after clamping the umbilical cord

DRUG

Carbetocin

Administration of carbetocin 100 mcg , after clamping the umbilical cord

Sponsors & Collaborators

  • Laval University

    lead OTHER

Principal Investigators

  • Julie Bédard · Laval University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01630187 on ClinicalTrials.gov